Breakout Sessions II
Beyond the Single Site: Growth Pathways Through SMOs & Site Networks
Scaling a research operation opens new doors — more studies, deeper therapeutic expertise, greater sponsor visibility, and stronger regional influence. For LATAM sites exploring growth, two distinct models offer compelling pathways: site management organizations (SMOs) and site networks. This session examines both, drawing on firsthand experience from LATAM leaders who have navigated each model, so sites can make informed decisions about which path aligns with their goals, capacity, and market context.
Country Roundtable — Mexico, Colombia, Peru
Mexico, Colombia, and Peru represent three of Latin America’s most compelling growth markets in clinical research. Mexico and Colombia share large, diverse, and largely treatment-naïve populations with high patient motivation, and both have regulatory bodies — COFEPRIS and INVIMA, respectively — actively modernizing to reduce approval timelines and increase predictability. Peru adds a distinct dimension: a highly diverse patient population, a steadily strengthening regulatory authority in DIGEMID, and growing Phase 2–3 opportunity that is placing the country on sponsor shortlists as a high-value complement to more established markets. Together, these countries represent a reform-driven, population-rich corridor with significant upside for sites positioned to capitalize on it.
Patient Recruitment Strategies In Competitive Markets
Patient recruitment is the heartbeat of every successful clinical trial, and the sites that master it have a lasting competitive advantage. As more sites across Latin America compete for eligible participants, the differentiator is not just outreach volume but strategy: community relationships, referral networks, digital tools, and a deep understanding of what moves patients from awareness to enrollment. This session shares what is working across LATAM markets and equips sites to build a recruitment infrastructure that delivers consistently across studies, therapeutic areas, and sponsor relationships.
Regulatory Landscape: Momentum & Opportunities Across LATAM
Latin America’s regulatory environment is evolving — and for well-prepared sites, that evolution represents opportunity. Significant reforms in Argentina, Brazil, Mexico, and other countries are reshaping approval timelines, multi-country execution, and the region’s overall competitiveness as a research destination. This session provides a current overview of where the regulatory landscape exists across key markets, what the data shows about real-world timeline improvements, and how sites can use this momentum to their advantage.